Jounce Therapeutics Inc
Biotechnology
Healthcare
JNCE
51.69 M shares
NASDAQ US
traded
03 May 2023
listed
yes
open
1.92
52 week high
8.54
high
1.93
52 week low
1.48
previous Close
1.93
P/E ratio
market cap
102 M
div yield
0
net incoming
50.96 M
264.39 %
net profit margin
62.15 %
62.00 %
operating incoming
50.34 M
260.29 %
net change in cash
73.46 M
11.00 %
cash on hand
151 M
95.27 %
top